LongCovid
“The full picture of post-COVID-19 autoimmune diseases and their prevalence is lacking despite numerous case reports and small series. Two studies that use large cohorts now highlight that…
Breaking news! The Long COVID flyer is out now. Visit the Communication Material section on our website to find the brand-new flyer presenting the main objectives, the methodology, the…
Study Highlights: – Reduced O2 pulse peak % predicted (impaired oxygen extraction) may be a mechanism of chronic fatigue and exercise intolerance in Long COVID. – The study identified…
This excellent new Long COVID review paper has just been published by the Trends in Endocrinology & Metabolism journal. In this paper, Etheresia Petrorius and her co-authors discuss the…
What was once outright denial has morphed into a subtler dismissal. In this article published by the Atlantic, Ed Young wrote about the current wave of attempts to…
New study assessed symptom severity and various biomarkers at three time points post infection (3-8 months, 9-16 months, 17-20 months) in 106 Post-COVID Syndrome (PCS) patients with moderate…
The results of a new study, published in the Lancet eClinical Medicine, showed that an experimental drug (AXA1125) significantly reduces fatigue in people with Long COVID. Scientists who carried out the…
A study recently published by Scientific Reports (Nature) identified a significative alteration of cerebral perfusion pattern in post-COVID-19 subjects who reported cognitive deficit by using a non-invasive ASL-MRI…
Save the date! Wednesday 10 May 7pm-8pm BST The public are invited to a free webinar to ask questions of a leading specialist about the latest research into…
A recent study led by Ali Ertürk (Director at Helmholtz Munich, Full Professor at LMU Munich) shows that ~60% of people who had COVID still might have lingering…